Expert opinion: Recommendation of diabetes experts on the use of FreeStyle Libre in diabetic patients in Poland

Abstract

On the basis of clinical trials, scientifc evidence and experience from everyday practice, the use of FreeStyle Libre is recommended as a glucose monitoring system in patients with type 1 and type 2 diabetes treated with intensive insulin therapy. FreeStyle Libre supports treatment and can contribute to: - improvement in diabetes control by decreasing mean blood glucose levels and HbA1c; - reduction of the number of hypoglycemic episodes and time spent in hypoglycemia; it is particularly relevant to patients with frequent hypoglycemic episodes and hypoglycemia unawareness; - reduced glycemic variability; - potential decrease in long-term complications of diabetes; - improved patient quality of life and safety. We express the opinion that the FreeStyle Libre system should be widely available, also taking into account its affordability, for Polish patients with type 1 and type 2 diabetes treated with intensive insulin therapy. The Expert Group was established by Abbott Laboratories Polska to express the above opinion as part of the meeting of the Advisory Committee, which was held in Warsaw on November 21, 2017 and on March 23, 2018.